Oxford Lane Capital Corp vs Tilray Brands Inc — how do they compare? Oxford Lane Capital Corp trades at $8.85 (market cap $861.22M), while Tilray Brands Inc trades at $4.19 (market cap $524.07M). The key difference: Oxford Lane Capital Corp is the larger of the two by market cap, and Oxford Lane Capital Corp pays a 27.21% dividend while Tilray Brands Inc pays none. Which is the better fit depends on your goals.
| OXLC | TLRY | |
|---|---|---|
Market Cap | $861.22M | $524.07M |
Sector | Financials | Health |
52-Week High | $19.90 | $21.00 |
52-Week Low | $8.15 | $4.23 |
Dividend Yield | 27.21% | — |
Enterprise Value | — | $621.22M |
Signals from Pluang's Aura AI — not financial advice
OXLC trades at $8.87, up 1.14% today, but faces a bearish technical outlook with significant selling pressure. The company reported a net income of $48.46 million for 2025, but recent quarterly earnings have consistently missed expectations, including a substantial miss in Q1 2026. Despite a high dividend yield, financial performance shows strain with negative ROE and ROA, while cash flow is heavily dependent on financing activities.
The outlook is cautious due to deteriorating fundamentals, negative profitability metrics, and bearish analyst sentiment. The primary opportunity lies in the high dividend yield, but risks include unsustainable distributions, declining net asset value, and potential for further earnings volatility. Investor caution is warranted given the conflicting signals between dividend income and underlying financial health.
TLRY trades at $4.23, down 1.63% on the day, with a bearish technical signal and negative earnings trends. The company reported a net loss of $2.19 billion in 2025 despite revenue growth to $821.31 million, reflecting deep profitability challenges. Analysts show cautious sentiment with 65% hold ratings, while recent news highlights expansion in medical cannabis and beverage segments amid ongoing regulatory uncertainty.
The outlook remains challenged by persistent losses and high debt-to-asset ratio of 12.25, though low P/S and P/B ratios suggest undervaluation. Key risks include profitability execution and federal cannabis policy shifts, while potential catalysts lie in international expansion and cost management improvements.
Trailing returns across standard periods
Latest headlines on both assets
Oxford Lane Capital Corp. is a non-diversified, closed-end management investment company. Its primary investment objective is to achieve high current income, with a secondary objective of capital appreciation. The company primarily invests in equity and junior debt tranches of collateralized loan obligations (CLOs), which are pools of corporate loans. OXLC is known for its high-yield distribution policy and provides investors with leveraged exposure to the CLO market.
Read more on OXLC →Tilray is a Canadian company that grows and sells medical and recreational cannabis. In 2021, Aphria acquired Tilray in a reverse merger and adopted the Tilray name. Most of its sales come from Canada and international medical cannabis exports, while its U.S. business focuses on CBD products and alcohol.
Read more on TLRY →